Inspire Investing’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Inspire Investing's NVAX Position: Q2 2022 in Review
Inspire Investing sold out of Novavax (NVAX) in Q2 2022, closing a stake of 6,834 shares — an estimated $503K sold.
Inspire Investing first reported a position in NVAX in Q4 2020 and held it in 5 quarters. The position peaked at $1.61M in Q3 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Inspire Investing reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Inspire Investing sold 6,834 Novavax shares in Q2 2022, an estimated $503K.
- Inspire Investing first reported a position in Novavax in Q4 2020 and held it in 5 quarters.
- Inspire Investing's Novavax position peaked at $1.61M in Q3 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Inspire Investing's 13F filing for Q2 2022, filed 10 Aug 2022.